XML 15 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segment Reporting
 6 Months Ended
Jun. 30, 2013
Segment Reporting [Abstract]  
Segment Reporting
11. Segment Reporting. The Company has five reportable segments: Apex, Oxford, Life Sciences, Physician, and Healthcare. The Company’s management evaluates the performance of each segment primarily based on revenues, gross profit and operating income. The information in the following table is derived directly from the segments’ internal financial reporting used for corporate management purposes.

The following table presents revenues, gross profit and operating income by reportable segment (in thousands):
 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2013
 
2012
 
2013
 
2012
Revenues:
 
 
 
 
 
 
 
Apex
$
233,446

 
$
98,503

 
$
446,174

 
$
98,503

Oxford
101,474

 
88,107

 
196,736

 
166,866

Life Sciences
41,877

 
40,509

 
82,350

 
81,860

Physician
26,466

 
25,039

 
52,768

 
49,128

Healthcare
14,660

 
13,705

 
29,088

 
26,266

 
$
417,923

 
$
265,863

 
$
807,116

 
$
422,623

Gross Profit:
 
 
 
 
 
 
 
Apex
$
63,896

 
$
26,983

 
$
119,515

 
$
26,983

Oxford
34,506

 
31,646

 
66,656

 
59,016

Life Sciences
13,838

 
13,808

 
27,222

 
27,647

Physician
7,640

 
7,718

 
15,123

 
15,217

Healthcare
4,687

 
4,382

 
9,325

 
8,423

 
$
124,567

 
$
84,537

 
$
237,841

 
$
137,286

Operating Income (Loss):
 
 
 
 
 
 
 
Apex
$
16,431

 
$
(3,648
)
 
$
26,510

 
$
(3,648
)
Oxford
14,020

 
15,521

 
25,436

 
22,756

Life Sciences
1,255

 
2,963

 
1,875

 
5,271

Physician
1,927

 
1,984

 
4,082

 
3,062

Healthcare
(795
)
 
(1,340
)
 
(1,331
)
 
(2,591
)
 
$
32,838

 
$
15,480

 
$
56,572

 
$
24,850


The Company operates internationally, with operations mainly in the United States, Europe, Canada, Australia and New Zealand. The following table presents domestic and foreign revenues (in thousands):

 
Three Months Ended
 
Six Months Ended
 
June 30,
 
June 30,
 
2013
 
2012
 
2013
 
2012
Revenues:
 
 
 
 
 
 
 
Domestic
$
398,803

 
$
246,875

 
$
767,601

 
$
384,319

Foreign
19,120

 
18,988

 
39,515

 
38,304

 
$
417,923

 
$
265,863

 
$
807,116

 
$
422,623


 
The Company does not report Life Sciences and Healthcare segments’ total assets separately as the field operations are largely combined. The following table presents total assets as allocated by reportable segment (in thousands):

 
June 30, 2013
 
December 31, 2012
Total Assets:
 
 
 
Apex
$
652,295

 
$
642,594

Oxford
238,724

 
231,211

Life Sciences and Healthcare
117,315

 
139,601

Physician
80,699

 
84,615

 
$
1,089,033

 
$
1,098,021